COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study
Research
[키워드] ACE2
adaptive
age
analysed
angiotensin-converting enzyme inhibitor
Asia
average
blocker
C-reactive protein
carried
CD19
CD4
CD8
Clinical course
cohorts
Comorbidities
country
Course
COVID-19
COVID-19 pandemic
COVID-19 severity
decrease
Deleterious
diabetes
disease
dyslipidaemia
effectors
enzyme
European
evidenced
Fatality rate
feature
form
health authorities
hospitalized patient
hypertension
hypertensive patient
immune system
Immunity
immunological
immunosenescence
inhibitor
innate response
interleukin 6
interleukin-6
Laboratory
Local
lymphocyte
Lymphocyte count
Lymphocytes
male
males
Mild
moderate
multicentre
natural killer
Older
outcome
Patient
Prognosis
protective effect
public health
ranged
receptor
renin-angiotensin system
reported
Result
Retrospective study
risk factor
SARS-COV-2 infection
severe acute respiratory syndrome coronavirus 2
severity
significantly lower
Spain
Spanish
spread to
subpopulation
the disease
was performed
[DOI] 10.1186/s12979-020-00194-w PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s12979-020-00194-w PMC 바로가기 [Article Type] Research